Warning: file_get_contents(http://normativacookie.promo.it/cookiebar/cookiebar.php?l=Previous issues&site=d3d3LmNhbmNlcndvcmxkLm9yZw==) [function.file-get-contents]: failed to open stream: HTTP request failed! HTTP/1.1 400 Bad Request in E:\SITI\CANCERWORLDWEB\2013\inc\header.php on line 85

Previous issues

Issue 30 May - June 2009

Issue 30 May - June 2009

» [Editorial] It's about living not just surviving » [Cover Story] Pat Price: asking the right questions » [e-Grand Round] Decision making for systemic treatment of non-small-cell lung cancer » [Drug Watch] Health rationing in Europe: can cancer get a fair hearing? » [Masterpiece] Closing the gap with the West » [Impact Factor] Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck » [Impact Factor] Optimal timing of surgery after preoperative chemoradiotherapy for rectal cancer » [Newsround] Newsround » [Systems & Services] Why are cancer patients still suffering unnecessary pain? » [Focus] Chemobrain: delving into possible mechanisms

Issue 29 March - April 2009

Issue 29 March - April 2009

» [Editorial] Europe's nurses: an untapped resource » [Cover Story] Emiel Rutgers: a surgeon for the genomic era » [e-Grand Round] New oncoplastic techniques can avoid mastectomy » [Masterpiece] New drug combinations are not the solution: Sweden's screening guru argues early detection is what works in breast cancer » [Spotlight on...] Helping women make the right choices: Europa Donna launches Breast Health Day » [Impact Factor] Which questions remain unanswered following the successful development of sorafenib in hepatocellular carcinoma? » [Impact Factor] How does extended lymphadenectomy influence practical care for patients with gastric cancer? » [Newsround] Newsround » [Patient Voice] Emaciated but not unloved Patients and carers need support to cope with the distressing effects of cachexia » [Systems & Services] Europe's rare cancer community calls for a more radical approach

Issue 28 January - February 2009

Issue 28 January - February 2009

» [Editorial] Senior, elderly, geriatric: we are all getting older » [Cover Story] Jean-Pierre Droz: We can do better for our older patients » [e-Grand Round] Combining hormonal therapy with local treatment in prostate cancer » [Drug Watch] Oncology's successes must not fail the heart » [Masterpiece] Siding with the vulnerable » [Best Cancer Reporter Award] Everyone deserves the best chance to survive » [Impact Factor] Adoptive transfer of antigen-specific CD4+ T cells in the treatment of metastatic melanoma » [Impact Factor] Determining the survival benefit of adjuvant radiotherapy in patients with node-positive head and neck cancer » [Newsround] Newsround » [Focus] The root of all evil?

Issue 27 November - December 2008

Issue 27 November - December 2008

» [Editorial] A window of opportunity » [Cover Story] Paolo Casali: the man with the method » [Grandround] Controversial issues in managing locally advanced head and neck cancers » [Drug Watch] When is it OK to randomise cancer patients to placebo? » [Masterpiece] A reverence for life in turbulent times » [Best Cancer Reporter Award] If nothing is done... » [Spotlight on...] Bringing truths about cancer to new audiences » [Impact Factor] Concomitant difluoromethylornithine/ sulindac chemoprevention of colorectal adenomas: a major clinical advance » [Impact Factor] The ROC ‘n' role of the multiplex assay for early detection of ovarian cancer » [Newsround] N E W S R O U N D » [Systems & Services] A diet of hopes and half-truths

Issue 26 September - October 2008

Issue 26 September - October 2008

» [Editorial] ECCO–ESMO: a powerful partnership » [Cover Story] Nadia Harbeck: breaking with convention » [e-Grand Round] The modern approach to managing locally advanced rectal cancer » [Drug Watch] Stopping trials prematurely: sorting the right decisions from the wrong » [Masterpiece] Balancing cure and care » [Best Cancer Reporter Award] The neglected magic bullet » [Impact Factor] Adjuvant EBRT improves survival in patients with lymph-node-negative pancreatic cancer » [Impact Factor] Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma » [Newsround] N E W S R O U N D » [Systems & Services] Why is cancer killing more men than women? » [Patient Voice] Why ‘plenty of bed rest' could be bad advice

Issue 25 July - August 2008

Issue 25 July - August 2008

» [Editorial] A question of human dignity » [Cover Story] Mike Richards: the man with the plan » [Grandround] The hopes and frustrations of a career in cancer » [Drug Watch] Personalised medicine: the dream and the reality » [Masterpiece] A scientist without borders » [Spotlight on...] Tackling cancer in the Middle East » [Impact Factor] Does prophylactic cranial irradiation reduce the incidence of brain metastases in extensive small-cell lung cancer? » [Impact Factor] Comparison of gemcitabine plus platinum analogue with gemcitabine alone in advanced pancreatic cancer » [Newsround] N E W S R O U N D » [Systems & Services] We're back! » [Patient Voice] Europe must tackle health illiteracy to avoid a health ‘underclass'

Issue 24 May - June 2008

Issue 24 May - June 2008

» [Editorial] Shameful statistics of pain » [Cover Story] Ulrik Ringborg: tackling the fragmentation of Europe's cancer efforts » [Grandround] Translating good science into new treatments » [Drug Watch] How Europe is taking on the big biobank challenge » [Masterpiece] The people's pharmacologist » [Best Cancer Reporter Award] “There's a shadow in your head” » [Spotlight on...] European Leukemia Network: making fragmentation a thing of the past » [Impact Factor] Outcomes after cisplatin alone or in combination regimens versus hydroxyurea during pelvic irradiation for cervical cancer » [Impact Factor] Are metastatic testicular tumours curable with high-dose chemotherapy and stem-cell rescue? » [Newsround] N E W S R O U N D » [Patient Voice] Protection of employment rights: still work in progress

Issue 23 March - April 2008

Issue 23 March - April 2008

» [Editorial] Diet and exercise: it's time to act on the evidence » [Cover Story] Giovanni Paganelli: nuclear medicine's enthusiastic ambassador » [Grandround] Personalised cancer therapies: why we may never reach the promised land » [Masterpiece] Scientific integrity must always come first » [Impact Factor] Are patients with multiple hepatic metastases from colorectal cancer candidates for surgery? » [Impact Factor] Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukaemia? » [Newsround] N E W S R O U N D » [Patient Voice] It's not just about surviving, it's about getting your life back » [Focus] To avoid the Big C, stay small

Issue 22 January - February 2008

Issue 22 January - February 2008

» [Editorial] Men's health matters too » [Cover Story] Clifton Leaf: asking the difficult questions » [Grandround] No trials about us without us! » [Grandround] Our responsibility, our choices » [Best Cancer Reporter Award] My wife has breast cancerÂ… » [Masterpiece] A very useful doctor » [Spotlight on...] ECCO seeks healing touch for oncology's lost voice » [Impact Factor] Does a prompt list help patients and caregivers to ask questions about cancer prognosis and care? » [Impact Factor] Does adjuvant radiotherapy increase survival in patients with Merkel cell carcinoma of the skin? » [Newsround] N E W S R O U N D » [Patient Voice] Surviving childhood cancer

Issue 21 November  - December 2007

Issue 21 November - December 2007

» [Editorial] Tackling the adherence crisis » [Cover Story] Hein Van Poppel: Urological cancer is what we do » [Grandround] Breast screening: a question of pros and cons not right or wrong » [Drug Watch] Dying for a lack of compassion? » [Masterpiece] The passion behind big cancer projects » [Best Cancer Reporter Award] Do-it-yourself Chemotherapy Access » [Spotlight on...] New breast care network seeks to push up standards across the globe » [Impact Factor] Is surgery necessary following chemoradiation for patients with locally advanced cancer of the oesophagus? » [Impact Factor] Is rituximab maintenance therapy useful following rituximab salvage in refractory or relapsed follicular lymphoma? » [Newsround] N E W S R O U N D » [Systems & Services] The X factor

Pagina 5 di 7       1 | 2 | 3 | 4 | 5 | 6 | 7